Idarac 200mg Roussel Treatment Treatment of mild to moderate pain (2 blisters x 10 tablets)

Dosage form Box of 2 blisters x 10 tablets
Specifications Floctafenine

Ingredient

Composition information	Content
Floctafenine	200mg

Uses

Indications

Idarac is indicated for treatment of mild to moderate pain.

Pharmacology

The drug has a mere analgesic effect that does not reduce fever and anti-inflammatory, belonging to the Nonsteroidal Anti-Inflammatory Drugs (NSAIDS).

Dynamic pharmacokinetics

Drugs are quickly absorbed by oral. Plasma concentration in plasma reaches a maximum of 1 hour to 2 hours after taking the drug. Selling time is about 8 hours.

In the liver, most of Floctafenin is converted into Floctafenic acid.

flucafenin and its metabolites are eliminated 60% in biliary tract and 40% via urinary tract in the form of glucuronid complex.

flocfenin passes the placenta and breast milk.

Before taking Idarac 200mg Roussel Treatment Treatment of mild to moderate pain (2 blisters x 10 tablets)

Dosage

only for adults.

Dosage may vary depending on the type of pain, from 200 - 400 mg/time, the dose is 6 to 8 hours apart.

Average 800 mg a day, maximum 1.2 g a day.

How to use

Drink with 1 IY water.

The drug can be taken in whole, or better, dissolved in water.

Always follow the doctor's instructions.

What to do when overdose?

What to do when you forget the dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Note that it should not be used double the prescribed dose.

Side Effects

When using Idarac 200 mg, you may experience unwanted side effects (ADR).

allergic deformations. These complications are rare but serious and the patient must not use this medication and the same drugs.

Allergic complications occur on average 30 minutes after taking the drug, with the feeling of the needle and hotness in the hands, feet and face, suddenly redness in the face or upper chest, laryngeal itching, skin rash or swelling of the eyelids, body rash (redness) and itching, body discomfort and can progress to loss of perception.

urticaria, nerve angioedema (swelling of the subject and larynx).

Asthma shortness.

Acute kidney disease with decreasing urine.

These disorders can occur in humans who have become sensitive to drugs due to previous use; Must stop taking the drug immediately, do not use the medicine and report to the doctor.

Very rare cases:

Nausea and vomiting.

drowsy.

A burning sensation when urinating.

Instructions for handling ADR

Notice to the doctor or pharmacist all the unwanted effects when using this drug.

Warnings

contraindicated

Idarac is not used in the following cases:

allergies to flocfenin or similar substances (Glafenin, Antrafenin).

Coordinate with beta blockers.

Severe heart failure.

Ischemic heart disease (some heart diseases with blood to raise fake hearts).

Note when using

avoid repeated use of solitary doses.

inform the doctor if there is a kidney disease.

pregnancy or lactation

better than not taking this medication during pregnancy. Idarac is also not assigned to use in women who are breastfeeding.

Should consult a doctor or pharmacist before taking any drug.

The ability to drive and operate machinery

Note the drivers and use machines about the risk of drowsiness when taking this drug.

Interactive drug

All drugs that patients are using must be notified to the doctor, especially: other nonsteroidal anti -inflammatory analgesic, warfarin, diuretics, diabetes, high blood pressure, anticoagulants, lithium, methotrexate, phenytoin ...

To avoid possible interactions, always inform the doctor or pharmacist of all other drugs in use.

Storage

Store in a dry place, temperatures below 30 ° C, avoiding light.

Expiry date: 36 months from the date of production.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.